Skip to main content
. 2020 Jul 6;32(9):1116–1122. doi: 10.1097/MEG.0000000000001785

Fig. 5.

Fig. 5.

Inflammatory markers (a) CRP (mg/L); (b) IgM (mg/dL) in patients with PBC treated with combination therapy vs. monotherapy. UDCA, ursodeoxycholic acid; IV, inverse-variance; CI, confidence interval; df, degrees of freedom; CRP, C-reactive protein; IgM, immunoglobulin M; PBC, primary biliary cholangitis.